SequelSEC

Tilray Brands, Inc. TLRY

Medicinal Chemicals & Botanical Products · CIK 0001731348 · Fiscal year ends 0531

AnnualQuarterlyTTM
Revenue
$963.10M
Fiscal year ended 2026-08-31
Operating income
-$89.17M
Fiscal year ended 2026-08-31
Free cash flow
Unavailable
Fiscal year ended 2026-08-31

Valuation, from the filing

Public float$900.00MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-11-28
Float per share$6.61Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue1.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-11-28, not today, and each multiple below it uses the figures for the fiscal year ending 2026-05-31 — the year that filing covered.

How this compares in its industry

Percentile among the Medicinal Chemicals & Botanical Products filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
R&D / revenue0.0%0th
SBC / revenue5.0%78th
Current ratio2.21x76th
Gross margin28.4%27th
Revenue YoY growth11.5%65th
Net margin-13.3%52th
Operating margin-6.9%52th

Tilray Brands, Inc. (TLRY) reported revenue of $963.10M and net income of -$164.22M for the fiscal year ended 2026-08-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Tilray Brands, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Medicinal Chemicals & Botanical Products.

Income

Tilray Brands, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Revenue$963.10M
Cost of revenue$682.62M
Gross profit$280.48M
Operating income-$89.17M
Net income-$164.22M
Research & development$409.00K
Weighted-average diluted sharesUnavailable
Pretax income-$125.59M
Income tax expense$21.11M
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$220.18M
Selling & marketingUnavailable

Balance

Tilray Brands, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Cash & equivalents$214.96M
Total assets$2.33B
Current assets$807.59M
Total liabilities$721.28M
Current liabilities$430.69M
Total equity incl. NCI$1.61B
Temporary (mezzanine) equityUnavailable
Inventory$328.97M
Accounts receivable$190.62M
Goodwill$752.35M
Long-term debt$118.05M
Accounts payable$133.60M

Cash flow

Tilray Brands, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Operating cash flow-$84.34M
Capital expendituresUnavailable
Investing cash flow-$89.52M
Financing cash flow$125.11M
Net change in cash-$46.48M
Stock-based compensation$47.47M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Tilray Brands, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-08-31
Free cash flowUnavailable
Gross margin29.1%
Operating margin-9.3%
FCF marginUnavailable
SBC / revenue4.9%
Current ratio1.88x
Revenue YoY growth15.9%
Net margin-17.1%
R&D / revenue0.0%
CapEx / revenueUnavailable
Long-term debt / equity0.07x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TLRY in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-08View SEC filing
10-K · Filed 2026-07-28View SEC filing
10-Q · Filed 2026-04-01View SEC filing
10-Q · Filed 2026-01-08View SEC filing
10-Q · Filed 2025-10-09View SEC filing
10-K · Filed 2025-07-29View SEC filing

Companies in the same industry

AAWH ADIA AIBT BTMD CBDY CFOO CGC CHUC CRON CYAN DFTX FTLF

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.